During the last three months, 10 analysts shared their evaluations of Procter & Gamble PG, revealing diverse outlooks from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 5 | 3 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 1 | 1 | 0 | 0 | 0 |
| 2M Ago | 1 | 1 | 1 | 0 | 0 |
| 3M Ago | 0 | 2 | 2 | 0 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $182.3, a high estimate of $209.00, and a low estimate of $160.00. This current average has increased by 2.99% from the previous average price target of $177.00.
Interpreting Analyst Ratings: A Closer Look
The analysis of recent analyst actions sheds light on the perception of Procter & Gamble by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Andrea Teixeira | JP Morgan | Lowers | Overweight | $181.00 | $186.00 |
| Chris Carey | Wells Fargo | Lowers | Overweight | $176.00 | $190.00 |
| Linda Bolton Weiser | DA Davidson | Maintains | Buy | $209.00 | $209.00 |
| Linda Bolton Weiser | DA Davidson | Raises | Buy | $209.00 | $160.00 |
| Chris Carey | Wells Fargo | Raises | Overweight | $190.00 | $188.00 |
| Linda Bolton Weiser | DA Davidson | Maintains | Neutral | $160.00 | $160.00 |
| Dara Mohsenian | Morgan Stanley | Raises | Overweight | $191.00 | $174.00 |
| Robert Ottenstein | Evercore ISI Group | Raises | Outperform | $183.00 | $180.00 |
| Nik Modi | RBC Capital | Maintains | Sector Perform | $164.00 | $164.00 |
| Linda Bolton Weiser | DA Davidson | Raises | Neutral | $160.00 | $159.00 |
Key Insights:
- Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Procter & Gamble. This information offers a snapshot of how analysts perceive the current state of the company.
- Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Procter & Gamble compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Procter & Gamble's stock. This comparison reveals trends in analysts' expectations over time.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Procter & Gamble's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Procter & Gamble analyst ratings.
All You Need to Know About Procter & Gamble
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
Key Indicators: Procter & Gamble's Financial Health
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Challenges: Procter & Gamble's revenue growth over 3 months faced difficulties. As of 30 September, 2024, the company experienced a decline of approximately -0.61%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Procter & Gamble's net margin excels beyond industry benchmarks, reaching 17.88%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Procter & Gamble's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 7.73%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 3.12%, the company showcases effective utilization of assets.
Debt Management: Procter & Gamble's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.71.
What Are Analyst Ratings?
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
